Making the Medicines of Tomorrow
As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow.
Founded in Switzerland in 1897, our company is the first and original CDMO. Today, we bring together a team of 18,500 colleagues across five continents to deliver integrated offerings that meet the complex needs of our global customer community.
Learn More About Us
Our Offering
Lonza’s stock
LONZA GROUP AG-REG
(LONN.SW: SIX Swiss Ex)
(LONN.SW: SIX Swiss Ex)
Last price:
CHF 541.60
Change today:
0.60 (%-0.11)